Literature DB >> 34125854

Active search strategies, clinicoimmunobiological determinants and training for implementation research confirm hidden endemic leprosy in inner São Paulo, Brazil.

Fred Bernardes Filho1,2, Claudia Maria Lincoln Silva1,2, Glauber Voltan1,2, Marcel Nani Leite1,2, Ana Laura Rosifini Alves Rezende1,2, Natália Aparecida de Paula1,2, Josafá Gonçalves Barreto3, Norma Tiraboschi Foss1,2, Marco Andrey Cipriani Frade1,2.   

Abstract

BACKGROUND: This study evaluates implementation strategies for leprosy diagnosis based on responses to a Leprosy Suspicion Questionnaire (LSQ), and analyzes immunoepidemiological aspects and follow-up of individuals living in a presumptively nonendemic area in Brazil. METHODOLOGY/PRINCIPAL
FINDINGS: Quasi-experimental study based on LSQ throughout Jardinópolis town by community health agents, theoretical-practical trainings for primary care teams, dermatoneurological examination, anti-PGL-I serology, RLEP-PCR, and spatial epidemiology. A Leprosy Group (LG, n = 64) and Non-Leprosy Group (NLG, n = 415) were established. Overall, 3,241 LSQs were distributed; 1,054 (32.5%) LSQ were positive for signs/symptoms (LSQ+). Among LSQ+ respondents, Q2-Tingling (pricking)? (11.8%); Q4-Spots on the skin? (11.7%); Q7-Pain in the nerves? (11.6%); Q1-Numbness in your hands and/or feet? (10.7%) and Q8-Swelling of hands and feet? (8.5%) were most frequently reported symptoms. We evaluated 479 (14.8%) individuals and diagnosed 64 new cases, a general new case detection rate (NCDR) of 13.4%; 60 were among 300 LSQ+ (NCDR-20%), while 4 were among 179 LSQ negative (NCDR-2.23%). In LG, Q7(65%), Q2(60%), Q1(45%), Q4(40%) and Q8(25%) were most frequent. All 2x2 crossings of these 5 questions showed a relative risk for leprosy ranging from 3 to 5.8 compared with NLG. All patients were multibacillary and presented hypochromatic macules with loss of sensation. LG anti-PGL-I titers were higher than NLG, while 8.9% were positive for RLEP-PCR. The leprosy cases and anti-PGL-I spatial mappings demonstrated the disease spread across the town.
CONCLUSIONS/SIGNIFICANCE: Implementation actions, primarily LSQ administration focused on neurological symptoms, indicate hidden endemic leprosy in a nonendemic Brazilian state.

Entities:  

Year:  2021        PMID: 34125854     DOI: 10.1371/journal.pntd.0009495

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  4 in total

1.  Serological Immunoassay for Hansen's Disease Diagnosis and Monitoring Treatment: Anti-Mce1A Antibody Response Among Hansen's Disease Patients and Their Household Contacts in Northeastern Brazil.

Authors:  Filipe Rocha Lima; Fred Bernardes Filho; Vanderson Mayron Granemann Antunes; Jaci Maria Santana; Regina Coeli Palma de Almeida; Diana Mota Toro; Vinicius Fozatti Bragagnollo; Gabriel Martins da Costa Manso; Natália Aparecida de Paula; Eliracema Silva Alves; Lee W Riley; Sérgio Arruda; Marco Andrey Cipriani Frade
Journal:  Front Med (Lausanne)       Date:  2022-06-09

2.  Leprosy case series in the emergency room: A warning sign for a challenging diagnosis.

Authors:  Fred Bernardes-Filho; Filipe Rocha Lima; Glauber Voltan; Natália Aparecida de Paula; Marco Andrey Cipriani Frade
Journal:  Braz J Infect Dis       Date:  2021-10-12       Impact factor: 3.257

3.  Bacilloscopy and polymerase chain reaction of slit-skin smears and anti-phenolic glycolipid-I serology for Hansen's disease diagnosis.

Authors:  Filipe Rocha Lima; Natália Aparecida de Paula; Mateus Mendonça Ramos Simões; Gabriel Martins da Costa Manso; Gustavo Sartori Albertino; Giovani Cesar Felisbino; Vanderson Mayron Granemann Antunes; Fernanda André Martins Cruz Perecin; Andrezza Telles Westin; Helena Barbosa Lugão; Marco Andrey Cipriani Frade
Journal:  Front Med (Lausanne)       Date:  2022-08-10

4.  Evaluation of altered patterns of tactile sensation in the diagnosis and monitoring of leprosy using the Semmes-Weinstein monofilaments.

Authors:  Marco Andrey Cipriani Frade; Fred Bernardes Filho; Claudia Maria Lincoln Silva; Glauber Voltan; Filipe Rocha Lima; Thania Loyola Cordeiro Abi-Rached; Natália Aparecida de Paula
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.